Company intelligence / Profile preview

AION Labs

Rehovot, Central, Israel

Ownership: Private
Development stage: Other

Overview

AION Labs itself is not a therapeutic developer but a venture studio: its incubated companies develop and validate AI technologies for drug discovery and development, with several having launched platforms for small molecule identification, antibody design, molecular glue therapies, clinical trial readiness, and epiproteomic analysis. Clinical results for these technologies are not reported at the company level; stages are mostly preclinical/technology validation

Therapeutic areas: ImmunologyOther
Modalities: Small moleculeAntibodyMolecular glue therapyEpiproteomic analysisComputational platform (for clinical trial readiness and drug safety)Biologic
Industry: Investors

Partnerships

PfizerMerckAstraZenecaTeva PharmaceuticalsAmazon Web Services (AWS)Israel Biotech FundBioMed X (Heidelberg)Israel Innovation Authority

Beyond the preview

Go deeper on AION Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AION Labs.

Explore the full profile